Cryo-EM structures reveal two allosteric inhibition modes of PI3Kα^H1047R involving a re-shaping of the activation...

Area of Science:

• Biochemistry
• Structural Biology
• Cancer Research

Background:

• Phosphoinositide 3-kinase alpha (PI3Kα) is a lipid kinase crucial for cell signaling.
• The H1047R mutation in PI3Kα drives approximately 14% of breast cancers, presenting a significant therapeutic target.
• Understanding the structural basis of PI3Kα inhibition is key for developing effective cancer treatments.

Purpose of the Study:

• To determine the cryo-electron microscopy (cryo-EM) structures of PI3Kα^H1047R bound to novel allosteric inhibitors.
• To elucidate the mechanism by which these inhibitors suppress the hyperactive kinase.
• To provide a structural foundation for the rational design of PI3Kα-targeted cancer drugs.

Main Methods:

• Cryo-electron microscopy (cryo-EM) to resolve high-resolution structures.
• Molecular Dynamics (MD) simulations to analyze inhibitor binding and effects.
• Biochemical assays to assess kinase activity (implied).

Main Results:

• Determined cryo-EM structures of PI3Kα^H1047R with allosteric inhibitors QR-7909 (2.7 Å) and QR-8557 (3.0 Å).
• Identified two distinct allosteric binding pockets located on opposite sides of the activation loop.
• Structural and MD analyses demonstrated that inhibitors reduce activation loop mobility, thereby inhibiting hyper-activity.

Conclusions:

• The identified binding sites and inhibitory mechanisms provide a strong rationale for developing selective PI3Kα^H1047R inhibitors.
• These findings support the advancement of novel drug candidates for treating cancers driven by PI3Kα mutations.
• The study offers a structural blueprint for future optimization of PI3Kα-targeted cancer therapies.